DBV Technologies (DBVT) Other financing activities (2020 - 2021)
DBV Technologies (DBVT) posted Other financing activities of $6000.0 for Q4 2021, up 250.0% sequentially from -$4000.0 in Q3 2021, and up 150.0% YoY from $2400.0 in Q4 2020.
DBV Technologies (DBVT) Other financing activities (2020 - 2021) Analysis & Trends
DBV Technologies has reported Other financing activities for 2 years, with the latest figure at $6000.0 in Q4 2021.
- Quarterly Other financing activities rose 150.0% year-over-year to $6000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $6000.0 (up 118.18% YoY) and the FY2021 annual result came in at -$15000.0, up 58.33% from the prior year.
- Other financing activities grew to $6000.0 in Q4 2021 per DBVT's latest filing, from -$4000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $6000.0 in Q4 2021 and troughed at -$17000.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | DBV Technologies | 6.08 Bn | 5.90 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 6,000.00 |
| Dec 31, 2021 | 6,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Mar 31, 2021 | -17,000.00 |
| Mar 31, 2021 | -17,000.00 |
| Dec 31, 2020 | -12,000.00 |
| Dec 31, 2020 | -12,000.00 |
| Sep 30, 2020 | -5,000.00 |
| Sep 30, 2020 | -5,000.00 |
| Jun 30, 2020 | -12,000.00 |
| Jun 30, 2020 | -12,000.00 |
| Mar 31, 2020 | -7,000.00 |
| Mar 31, 2020 | -7,000.00 |